Sensile Medical’s aim is to provide leadership in medical devices development based on innovative technology improving people’s quality of care and management.

Objectives:

• Develop and produce innovative nanoliter-based medical devices for glucose monitoring and drug delivery systems that meet both the needs of drug-dependent people and those requiring care in intensive care units.
• Develop products that are safe, easy to use and inexpensive. They meet all regulatory requirements of the medical device industry.
• Conduct research in close partnership with the Swiss Federal Institute of Technology in Lausanne (EPFL), Switzerland
• Produce and market products in collaboration with academic and commercial partners.
• Establish and secure intellectual property (IP) rights and generate financial value for shareholders, employees, and partners.

Promote and nurture an open, dynamic, and enthusiastic work environment.